Meningococcal ACWY Vaccine (MenACWY)
MenACWY protects against four groups (A, C, W and Y) of the meningococcus bacterium, which can cause meningitis and blood poisoning within hours. The CDC schedule gives doses at 11–12 years and 16 years.

Meningococcal disease is uncommon but devastating: the bacteria can cause meningitis and a rapidly progressing bloodstream infection with a distinctive rash, killing within a day even with treatment, and leaving some survivors with hearing loss, brain injury or limb amputations. Teenagers and young adults carry the bacteria most often, and outbreaks occur in dormitories and barracks.
MenACWY links the sugar coats of groups A, C, W and Y to a carrier protein. It does not cover group B — that is the separate MenB vaccine.
What this vaccine protects against
- Meningococcal meningitis — infection of the membranes around the brain and spinal cord.
- Meningococcal sepsis — bloodstream infection with a purpuric (non-blanching) rash.
- Disease caused by meningococcal groups A, C, W and Y.
Who should get it, and when
All adolescents: dose 1 at 11–12 years and a booster at 16 years. First-year college students living in residential housing who were not vaccinated at 16 or later, and military recruits, should receive 1 dose.
Teens first vaccinated at 13–15 get a booster at 16–18; those first vaccinated at 16 or later need no routine booster.
Children from 2 months of age with certain risk conditions — no spleen or a damaged spleen (including sickle cell disease), HIV, complement deficiency, or use of complement-inhibitor medicines — follow an earlier, multi-dose schedule, as do travellers to the African meningitis belt and people going on Hajj.
What happens at the vaccination visit
- A single injection into the upper arm.
- It can be given at the same visit as MenB vaccine if both are due, at a different site.
How to prepare
- Bring the record — booster timing depends on the age at the first dose.
- Tell the clinician if your teen has no spleen, sickle cell disease, HIV, or takes a complement inhibitor such as eculizumab, as the schedule changes.
What to expect afterwards
A sore, red arm for a day or two, mild fever and headache are the usual effects.
Fainting precautions apply to teenagers, as with all adolescent injections.
Who should not get it, or should ask first
- A previous severe allergic reaction to a MenACWY vaccine or component is a contraindication.
- Moderate or severe illness is a reason to wait.
- People at risk because of complement deficiency should know vaccination reduces but does not eliminate their risk — they should still seek urgent care for fever.
Benefits
- Strong protection against four of the five main disease-causing meningococcal groups.
- The 16-year booster covers the late-teen years, when risk and carriage peak.
Limits and possible harms
- Mostly brief arm soreness; serious reactions are rare.
- Does not protect against meningococcal group B — a separate vaccine (MenB) covers that group.
Watch: related videos
Useful links and tools
More in Teen Vaccines
Frequently asked questions
If my child had MenACWY at 11, why is another dose needed at 16?
Protection wanes over about 5 years, and risk rises again in the later teens — especially for those heading to dormitories or barracks. The CDC schedule therefore pairs the 11–12 year dose with a booster at 16.
Does MenACWY cover all meningitis?
No. It covers meningococcal groups A, C, W and Y. Group B needs the separate MenB vaccine, and meningitis has other causes entirely — including viruses and other bacteria covered by the childhood Hib and pneumococcal vaccines.
This guide explains how a vaccine is usually given and who it is generally offered to, following the CDC immunization schedules. It is general educational information only — not medical advice, and not a recommendation for you personally. Whether a vaccine is right for you depends on your age, health and history, so talk to your own clinician or pharmacist. If you are ill now, seek medical care promptly rather than waiting for a vaccination appointment.